Celgene reports fourth quarter and full year 2014 operating and financial results
Celgene reported fourth quarter total revenue increased 19 percent to $2,085 million versus $1,756 million in the same 2013 period. Adjusted net income for the fourth quarter of 2014 increased 29 percent to $840 million compared to $649 million in the fourth quarter of 2013. January 29, 2015